Anne-esther Nlend-Njom

Yaounde, CE, Cameroon

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Low Rates of Virologic Failure and Acquired HIV-1 Drug Resistance Among Children in Cameroon: Evidence Following Transition to Dolutegravir-based Regimens in Pediatrics.

Low Rates of Virologic Failure and Acquired HIV-1 Drug Resistance Among Children in Cameroon: Evidence Following Transition to Dolutegravir-based Regimens in Pediatrics.

Journal: The Pediatric infectious disease journal

Published: January 07, 2026

Updates on the Clinical Epidemiology of HIV-1 Group O Strains in Cameroon and Potential Implications on Diagnosis and Treatment Strategies.

Updates on the Clinical Epidemiology of HIV-1 Group O Strains in Cameroon and Potential Implications on Diagnosis and Treatment Strategies.

Journal: The Journal of molecular diagnostics : JMD

Published: April 22, 2025

Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon.

Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon.

Journal: Journal of the International Association of Providers of AIDS Care

Published: December 23, 2024

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics.

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics.

Journal: Medicine

Published: June 19, 2023

Determinants of survival of adolescents receiving antiretroviral therapy in the Centre Region of Cameroon: a multi-centered cohort-analysis.

Determinants of survival of adolescents receiving antiretroviral therapy in the Centre Region of Cameroon: a multi-centered cohort-analysis.

Journal: AIDS research and therapy

Published: May 04, 2023

Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.

Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.

Journal: HIV medicine

Published: June 14, 2021

Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.

Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.

Journal: Tropical medicine & international health : TM & IH

Published: April 27, 2021

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).

Journal: BMC pediatrics

Published: April 29, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026